Loading organizations...
§ Venture Capital · Dallas, TX, USA
Omnimed develops specialized software solutions for the healthcare industry. Its core offering, OMNIMED® SmartOR™, is an AI-powered autonomous monitoring platform capturing real-time operating room data using sensors and networked technologies to enhance surgical efficiency and decision-making. Additionally, Omnimed provides a comprehensive web-based electronic medical record (EMR) system, centralizing patient information and connecting stakeholders to streamline workflows for improved care.
Established in 1998, Omnimed was founded on the insight that digital innovation could profoundly transform healthcare information management. The company began by designing and deploying sophisticated systems for the health sector, dedicated to enhancing patient care through technology. While specific founder details are not publicly prominent, the firm's long-standing presence reflects a foundational commitment to advancing healthcare IT solutions.
Omnimed's products serve diverse healthcare professionals, including administrators, clinicians, and risk management teams. Their solutions empower users to optimize operations, elevate patient outcomes, and mitigate institutional risks. The company envisions an integrated, intelligent data ecosystem fostering greater accuracy, productivity, and collaboration across healthcare, continuously striving for advancements benefiting both providers and patients.
Omnimed Capital has 3 tracked investments across 2 companies. The latest tracked deal is $100.0M Series B in Pryon in September 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2023 | Pryon | $100.0M Series B | US Innovative Technology Fund | 7BC Venture Capital, Alumni Ventures, Aperture Venture Capital, BBG Ventures, BootstrapLabs, Canaan Partners, Champion Hill Labs, Cota Capital, Crosscut Ventures, Matt Ocko, EVE Atlas, Scott Hartley, Feenix Ventures, Gaingels, Good Growth Capital, Ingeborg Investments, LombardStreet Ventures, MAC Venture Capital, Modern Venture Partners, Newfund, NightDragon, Parkway VC, Proton Enterprises, Revolution, Spark Capital, TWO Sigma Ventures, What IF Ventures, Anthony Pompliano, Catherine LU, Hoda Eydgahi, SAM Palmisano, Scot Wingo, Thomas Tull, Will Szczerbiak, Breyer Capital, Duke Angel Network, Revolution Growth |
| Apr 1, 2023 | Pattern Bioscience | $29.0M Series C | Illumina Ventures, Omnimed Capital | Transformation Capital, AMR Action Fund, Daleshaw |
| Jul 1, 2020 | Pattern Bioscience | $6.0M Series B | Illumina Ventures | Transformation Capital |